Understanding the complex interaction between feline hyperthyroidism and concurrent cardiac disease.
The interaction between hyperthyroidism and concurrent cardiac and renal disease creates a complex welfare management challenge. Hyperthyroidism causes secondary HCM from the effects of excess thyroid hormone on cardiac muscle — the heart thickens and stiffens. Treating the hyperthyroidism allows some cardiac remodelling in cats with pure secondary HCM. However, cats with underlying primary HCM may deteriorate when thyroid status is normalised.
The kidney-thyroid interaction is the most clinically challenging aspect. Hyperthyroidism increases glomerular filtration rate — some cats with underlying CKD maintain apparently normal kidney function while hyperthyroid. Normalising thyroid status unmasks the underlying CKD, which may be severe. This is not treatment failure but disease disclosure that requires renal management.
Welfare management requires a staged approach: trial of reversible treatment (methimazole or controlled-release iodine diet) before committing to radioiodine or surgery allows assessment of renal function when euthyroid. This staged approach protects against inadvertently causing renal crisis through definitive treatment.